2018
DOI: 10.1124/mol.118.114231
|View full text |Cite
|
Sign up to set email alerts
|

S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization

Abstract: Quinone reductase 2 (QR2, E.C. 1.10.5.1) is an enzyme with a feature that has attracted attention for several decades: in standard conditions, instead of recognizing NAD(P)H as an electron donor, it recognizes putative metabolites of NADH, such as N-methyl-and N-ribosyl-dihydronicotinamide. QR2 has been particularly associated with reactive oxygen species and memory, strongly suggesting a link among QR2 (as a possible key element in pro-oxidation), autophagy, and neurodegeneration. In molecular and cellular ph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
15
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 84 publications
2
15
0
Order By: Relevance
“…This result was further confirmed by the detection of the glucuronide form of menadiol. In a more general context, after having pointed out the ambiguous role of NQO2 as a detoxifying enzyme (Boutin et al, 2019;Janda et al, 2020), we present data clearly showing that in more relevant conditions, for example in the presence of the conjugating enzyme(s), NQO2 would recuperate its detoxifying role, in line with the NQO1 one. In this pathway, NQO2 acts as a drug metabolizing Phase I enzyme, leading to an 'activated' molecule that can be conjugated by Phase II enzymes of the next step of drug metabolizing machinery.…”
Section: Discussionmentioning
confidence: 61%
“…This result was further confirmed by the detection of the glucuronide form of menadiol. In a more general context, after having pointed out the ambiguous role of NQO2 as a detoxifying enzyme (Boutin et al, 2019;Janda et al, 2020), we present data clearly showing that in more relevant conditions, for example in the presence of the conjugating enzyme(s), NQO2 would recuperate its detoxifying role, in line with the NQO1 one. In this pathway, NQO2 acts as a drug metabolizing Phase I enzyme, leading to an 'activated' molecule that can be conjugated by Phase II enzymes of the next step of drug metabolizing machinery.…”
Section: Discussionmentioning
confidence: 61%
“…Notably, Compounds 1 , 3 , 4 and 6 produced radicals, whereas no radicals were detected for 2 , 5 and 7 . For the first three compounds ( 1 , 3 and 4 ), the radical production decreased after adding the specific NQO2 inhibitor S29434 [17], confirming that radicals originate in part from the autoxidation of the enzymatically reduced quinone.…”
Section: Resultsmentioning
confidence: 99%
“…We measured the ability of the selected compounds to produce superoxide radicals during the redox cycle of NQO2 by EPR spectroscopy. The following compounds were used as molecular tools: Menadione (Figure 1) as a reference compound and NQO2 substrate, S29434 as a specific NQO2 inhibitor [17] and dimethyl-pyrroline- N -oxide (DMPO) as a spin trap reagent to characterize ROS. Different EPR profiles were obtained, depending on the compound structures as illustrated in Figure 2 for menadione and Compounds 1 and 3 .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The abovementioned comments address some of the controversies and/or difficulties concerning fundamental aspects of the MLT field 137 . It would be pretentious to claim to know the answer to all these questions that have occupied researchers in the field for decades.…”
Section: Conclusion and Tentative Guidelinesmentioning
confidence: 99%